- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04804631
Tube Feeding in Children Having a Bone Marrow Transplant
A Mixed Methods Study Investigating Complications, Outcomes and Family Experiences of Gastrostomy Feeding in Paediatric Allogeneic Bone Marrow Transplantation
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background: Bone marrow transplant (BMT) is the only potentially curative treatment for children with malignant and non-malignant diseases. Chemotherapy provided during BMT causes side-effects including diarrhoea and vomiting meaning all children become unable to eat and require tube feeding. All 16 centres in the UK use a nasogastric tube. Great Ormond Street Hospital offer families a gastrostomy as an alternative. Minimal published literature exists on gastrostomies in this population.
Aims: Investigate complications, outcomes and family experiences of gastrostomy tubes in paediatric BMT.
Objectives:
- Survey current nutrition practices, use and opinions towards gastrostomy tubes in UK paediatric BMT centres.
- Compare clinical outcomes and complications occurring from gastrostomy versus nasogastric tubes in children during BMT.
- Investigate decision making and experiences of families regarding tube feeding.
Methods: A multiphase, convergent parallel mixed methods study across 3 work packages (WPs).
- Survey: A survey will be sent to a dietitian, nurse and doctor (the staff involved in tube feeding) in each UK paediatric BMT centre. Questions will focus on nutrition practices, and current use and opinions of gastrostomies.
- Prospective cohort study: Outcomes will be compared between children fed via gastrostomy versus nasogastric tube from admission to six months post-BMT. All children transplanted over one year at one centre will be included. Outcomes including complications occurring with both tubes, dietary intake and anthropometry will be investigated. Anticipated sample size is 9-15 children fed via gastrostomy, 30-50 via nasogastric tube.
- Family interviews: Families from WP 2 will be invited to be interviewed at two times; on admission to discuss why they did or did not choose a gastrostomy, and one month after discharge to discuss their experience of tube feeding. Creative methods including drawing and scrapbooks will be used during children's interviews to help them articulate their thoughts. Parents will take part in semi-structured interviews.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, WC1N3JH
- Great Ormond Street Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Admitted to the centre during the study period for an allogeneic bone marrow transplant (BMT) for any diagnosis.
- Receiving any conditioning regimen, donor type and stem cell source.
- Children admitted for their second or more BMT.
- Children admitted on an established enteral tube feeding regimen.
- NHS patients.
Exclusion Criteria:
- Children receiving first-line, prophylactic, parenteral nutrition as this is not the standard nutrition pathway of most children receiving BMT at the centre. This is usually given in specific circumstances such as children receiving cord blood transplants or those with gastrointestinal diseases.
- Autologous BMT, including children receiving chimeric antigen receptor T-cell therapy (CAR-T).
- No feeding tube placed and no nutrition support required from tube feeding or parenteral nutrition. Children rarely do not require any form of nutrition support.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Gastrostomy tube
Prophylactic gastrostomy placed prior to bone marrow transplant.
|
Families within Great Ormond Street Hospital are offered the choice of two enteral feeding tubes prior to admission for bone marrow transplant.
Some families choose a gastrostomy to be placed prophylactically in the weeks prior to admission, others choose a nasogastric tube to be placed during the admission.
|
Nasogastric tube
Nasogastric tube placed during admission.
|
Families within Great Ormond Street Hospital are offered the choice of two enteral feeding tubes prior to admission for bone marrow transplant.
Some families choose a gastrostomy to be placed prophylactically in the weeks prior to admission, others choose a nasogastric tube to be placed during the admission.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Weight Z-score
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Change in weight Z-score between groups.
Measured using ward scales.
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastrostomy tube complications
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to tube removal or six months post-transplant, whichever comes first (6 months)
|
Categorical reporting of the incidence of any complications occurring with the gastrostomy tube e.g.
infection, dislodgement, blockage
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to tube removal or six months post-transplant, whichever comes first (6 months)
|
Nasogastric tube complications
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to tube removal or six months post-transplant, whichever comes first (6 months)
|
Categorical reporting of the incidence of any complications occurring with the nasogastric tube e.g.
dislodgement, blockage
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to tube removal or six months post-transplant, whichever comes first (6 months)
|
Height Z-score
Time Frame: Measured monthly from admission to six months post-transplant (6 months)
|
Change in height Z-score between groups.
Measured using ward stadiometer.
|
Measured monthly from admission to six months post-transplant (6 months)
|
Body mass index (BMI) Z-score
Time Frame: Measured monthly from admission to six months post-transplant (6 months)
|
Change in BMI Z-score between groups.
Weight and height will be combined to report BMI in kg/m^2 and converted to Z-scores.
|
Measured monthly from admission to six months post-transplant (6 months)
|
Mid-upper-arm circumference (MUAC) Z-score
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Change in MUAC Z-score between groups.
Measured using ward measuring tape.
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Overall survival
Time Frame: Measured for all children at day-100 post-transplant
|
Percentage of children alive (with death from any cause) 100 days post-bone marrow transplant
|
Measured for all children at day-100 post-transplant
|
Non-relapse mortality
Time Frame: Measured for all children at day-100 post-transplant
|
Percentage of children alive (with death not caused by disease relapse) 100 days post-bone marrow transplant
|
Measured for all children at day-100 post-transplant
|
Graft-versus-host disease grade III-IV
Time Frame: Measured for all children at day-100 post-transplant
|
Percentage of children with grade III-IV graft-versus-host disease (measured using modified Gluckberg classification) 100 days post-bone marrow transplant
|
Measured for all children at day-100 post-transplant
|
Gastrointestinal graft-versus-host disease
Time Frame: Measured for all children at day-100 post-transplant
|
Percentage of children with gut graft-versus-host disease (measured using modified Gluckberg classification) 100 days post-bone marrow transplant
|
Measured for all children at day-100 post-transplant
|
Calorie intake
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Average intake of calories (total kcal intake and kcals/kg) provided from oral, enteral and parenteral nutrition, averaged over 3-days, measured from the hospital's electronic patient records during the bone marrow transplant admission, and thereafter once the child is at home from 3-day food diaries recorded once per month.
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Protein intake
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Average intake of protein (total protein intake and grams/kg) provided from oral, enteral and parenteral nutrition, averaged over 3-days, measured from the hospital's electronic patient records during the bone marrow transplant admission, and thereafter once the child is at home from 3-day food diaries recorded once per month.
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Fluid intake
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Average intake of fluid (total fluid intake and ml/kg) provided from oral, enteral and parenteral nutrition, averaged over 3-days, measured from the hospital's electronic patient records during the bone marrow transplant admission, and thereafter once the child is at home from 3-day food diaries recorded once per month.
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Duration of enteral nutrition
Time Frame: Measured from admission for bone marrow transplant to tube removal or discharge home post-transplant, whichever comes first. (Hospital admission is usually 3 months)
|
Total number of days enteral nutrition is provided during admission for bone marrow transplant
|
Measured from admission for bone marrow transplant to tube removal or discharge home post-transplant, whichever comes first. (Hospital admission is usually 3 months)
|
Duration of parenteral nutrition
Time Frame: Measured from admission for bone marrow transplant to tube removal or discharge home post-transplant, whichever comes first. (Hospital admission is usually 3 months)
|
Total number of days parenteral nutrition is provided during admission for bone marrow transplant
|
Measured from admission for bone marrow transplant to tube removal or discharge home post-transplant, whichever comes first. (Hospital admission is usually 3 months)
|
Use of enteral feeding tube
Time Frame: Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Categorical description of what the enteral feeding tube is used for.
Categories include: "Not in use", "Nutrition only", "Medicines only", "Fluids only", "Nutrition & medicines", "Medicines & fluids", "Nutrition, medicines & fluids".
|
Measured weekly for six weeks from admission for bone marrow transplant, and monthly thereafter to six months post-transplant (6 months)
|
Blood copper level
Time Frame: Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Change in blood copper level (micromol/L) during admission for bone marrow transplant
|
Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Blood selenium level
Time Frame: Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Change in blood selenium level (micromol/L) during admission for bone marrow transplant
|
Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Blood zinc level
Time Frame: Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Change in blood zinc level (micromol/L) during admission for bone marrow transplant
|
Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Blood vitamin A level
Time Frame: Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Change in blood vitamin A level (micromol/L) during admission for bone marrow transplant
|
Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Blood vitamin E level
Time Frame: Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Change in blood vitamin E level (micromol/L) during admission for bone marrow transplant
|
Measured monthly from admission for bone marrow transplant until the child is discharged home following the transplant (hospital admission is usually 3 months)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Faith Gibson, Professor, Great Ormond Street Hospital
Publications and helpful links
General Publications
- Evans J, Needle JJ, Hirani SP. Early outcomes of gastrostomy feeding in paediatric allogenic bone marrow transplantation: A retrospective cohort study. Clin Nutr ESPEN. 2019 Jun;31:71-79. doi: 10.1016/j.clnesp.2019.02.014. Epub 2019 Mar 21.
- Gonzales F, Bruno B, Alarcon Fuentes M, De Berranger E, Guimber D, Behal H, Gandemer V, Spiegel A, Sirvent A, Yakoub-Agha I, Nelken B, Duhamel A, Seguy D. Better early outcome with enteral rather than parenteral nutrition in children undergoing MAC allo-SCT. Clin Nutr. 2018 Dec;37(6 Pt A):2113-2121. doi: 10.1016/j.clnu.2017.10.005. Epub 2017 Oct 12.
- Hoffmeister PA, Storer BE, Macris PC, Carpenter PA, Baker KS. Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies. Biol Blood Marrow Transplant. 2013 Jul;19(7):1081-6. doi: 10.1016/j.bbmt.2013.04.017. Epub 2013 Apr 25.
- Trehan A, Viani K, da Cruz LB, Sagastizado SZ, Ladas EJ. The importance of enteral nutrition to prevent or treat undernutrition in children undergoing treatment for cancer. Pediatr Blood Cancer. 2020 Jun;67 Suppl 3:e28378. doi: 10.1002/pbc.28378.
- McGrath KH, Hardikar W. Gastrostomy tube use in children with cancer. Pediatr Blood Cancer. 2019 Jul;66(7):e27702. doi: 10.1002/pbc.27702. Epub 2019 Mar 11.
- Williams-Hooker R, Adams M, Havrilla DA, Leung W, Roach RR, Mosby TT. Caregiver and health care provider preferences of nutritional support in a hematopoietic stem cell transplant unit. Pediatr Blood Cancer. 2015 Aug;62(8):1473-6. doi: 10.1002/pbc.25473. Epub 2015 Mar 21.
- Peric Z, Botti S, Stringer J, Krawczyk J, van der Werf S, van Biezen A, Aljurf M, Murray J, Liptrott S, Greenfield DM, Duarte RF, Ruutu T, Basak GW. Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT. Bone Marrow Transplant. 2018 Aug;53(8):1030-1037. doi: 10.1038/s41409-018-0137-1. Epub 2018 Mar 7.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19SH04
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrostomy
-
Centre Hospitalier de ValenceRecruitingGastrostomy | Gastrostomy ComplicationsFrance
-
University Health Network, TorontoUnknown
-
University Medical Centre LjubljanaEuropean Society of Pediatric Gastroenterology, Hepatology and NutritionUnknownGastrostomyUnited Arab Emirates, United Kingdom, Belgium, Croatia, Italy, Slovenia, Switzerland
-
CoapTechChildren's Hospital of Philadelphia; Columbia University; Children's National...RecruitingGastrostomy | Pediatric Disorder | Ultrasound | Gastrostomy ComplicationsUnited States
-
University of TennesseeLe Bonheur Children's HospitalCompletedGastrostomy Complications | Gastrostomy Tube Site ComplicationUnited States
-
University of Sao PauloCompletedGastrostomy Tube Rupture | Gastrostomy Tube Durability | Gastrostomy Tube ConvenienceBrazil
-
CoapTechLondon Health Sciences CentreCompleted
-
Yonsei UniversityCompleted
-
St. Louis UniversityTerminated
Clinical Trials on Enteral feeding tubes
-
Xinhua Hospital, Shanghai Jiao Tong University...Children's Hospital of Fudan University; Shanghai Children's Hospital; Shanghai...UnknownEnteral Feeding | Ventilator-Associated Pneumonia
-
Lady Hardinge Medical CollegeAll India Institute of Medical Sciences, New DelhiCompletedTime for Achievement of Full Feeds
-
Brno University HospitalRecruitingEnteral Feeding IntoleranceCzechia
-
Lady Hardinge Medical CollegeRecruitingEnteral Feeding Intolerance | Very Preterm Maturity of InfantIndia
-
Centre Hospitalier Intercommunal CreteilLe Laboratoire de Psychopathologie et Processus de SantéEnrolling by invitationParent-Child Relations | PrematureFrance
-
Brno University HospitalMasaryk UniversityRecruiting
-
Second Affiliated Hospital, School of Medicine,...WithdrawnEnteral Nutrition | Dietary FiberChina
-
Centre Hospitalier Departemental VendeeInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsTerminatedShock | Acute Respiratory FailureFrance
-
Lady Hardinge Medical CollegeCompletedNutrition of Preterm InfantsIndia
-
Centre Hospitalier Departemental VendeeInstitut National de la Santé Et de la Recherche Médicale, France; Ministry... and other collaboratorsTerminatedShock | Acute Respiratory FailureFrance